Tom A Mulder

4PUBLICATIONS
20CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 26, 2025
T-cell immunomodulation occurs with different time kinetics during acalabrutinib and zanubrutinib therapy in chronic lymphocytic leukaemia.

Maria L Andersson, Olina Lind, Kia Heimersson

|Nov 27, 2024
A Small Molecule Antagonist of CX3CR1 (KAND567) Inhibited the Tumor Growth-Promoting Effect of Monocytes in Chronic Lymphocytic Leukemia (CLL).

Wen Zhong, Parviz Kokhaei, Tom A Mulder

|Jul 18, 2022
Temporary cessation of ibrutinib results in reduced grade 3-4 infections and durable remissions-Interim analysis of an on-off-repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia.

Jeanette Lundin, Tom A Mulder, Magdalena Kättström

|Mar 24, 2018
Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients.

Marzia Palma, Lotta Hansson, Tom A Mulder

Pageof 1

Frequent Collaborators

3 joint publications

Marzia Palma

2 joint publications

Lotta Hansson

2 joint publications

Anders Österborg

1 joint publications

Fariba Mozaffari